FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Metformin 750 mg Extended Release NDC # Recall

Metformin 750 mg Extended Release NDC # 70518-2920-00

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Jan 19, 2022
Recall ID
D-0366-2022
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Metformin 750 mg Extended Release NDC # starting Dec 30, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0366-2022 on Jan 19, 2022. Reason: CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. Status: Terminated.

Why it was recalled

CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Product description

Metformin 750 mg Extended Release NDC # 70518-2920-00

Lot numbers, UPCs & expiration codes

Lot # J0511265-021121, exp. date 02/28/2022 J0499451-122220, exp. date 01/31/2022 J0496563-120820, exp. date 12/31/2021 J0495111-120120, exp. date 12/31/2021

Where it was sold

Product was distributed to one direct account in PA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0366-2022
Classification
Class II
Status
Terminated
Recall initiated
Dec 30, 2021
FDA report date
Jan 19, 2022
Quantity
56 Blister Cards
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0366-2022, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
89331
Address
625 Kolter Dr Ste 4
Code information
Lot # J0511265-021121, exp. date 02/28/2022 J0499451-122220, exp. date 01/31/2022 J0496563-120820, exp. date 12/31/2021 J0495111-120120, exp. date 12/31/2021
Postal code
15701-3571
Report date
Jan 19, 2022
Product type
Drugs
Recall number
D-0366-2022
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
56 Blister Cards
Termination date
Mar 28, 2022
Reason for recall
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin 750 mg Extended Release NDC # 70518-2920-00
Distribution pattern
Product was distributed to one direct account in PA.
Recall initiation date
Dec 30, 2021
Initial firm notification
Letter
Center classification date
Jan 11, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0366-2022, published Jan 19, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls